PEPG INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PepGen Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / July 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or "the Company") (NASDAQ:PEPG) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants […]

RBGLY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Reckitt Benckiser Group PLC Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / July 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Reckitt Benckiser Group PLC ("Reckitt" or "the Company") (OTCMKTS:RBGLY) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

BRMK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Broadmark Realty Capital Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / July 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Broadmark Realty Capital Inc. ("Broadmark" or "the Company") (NYSE:BRMK), Ready Capital Corporation ("Ready Capital") (NYSE: RC), and certain officers. Class Definition This

FTRE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Fortrea Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / July 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

URGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of UroGen Pharma Ltd. to Contact the Firm Today!

NEW YORK CITY, NY / ACCESS Newswire / July 22, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UroGen Pharma Ltd. ("UroGen" or "the Company") (NASDAQ:URGN) and certain of its officers. Class Definition This lawsuit seeks to recover

FINAL REMINDER RCAT DEADLINE: Bronstein, Gewirtz and Grossman, LLC Announces that Red Cat Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / July 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Red Cat Holdings, Inc. ("Red Cat" or "the Company") (NASDAQ:RCAT) and certain of its officers. Class Definition This lawsuit seeks to recover damages

FINAL REMINDER OGN DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Organon & Co. Investors to Participate in the Class Action Lawsuit

NEW YORK CITY, NY / ACCESS Newswire / July 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. ("Organon" or "the Company") (NYSE:OGN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESS Newswire / July 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ:SRPT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

ProMIS Neurosciences Announces Private Placement Financing

(NASDAQ:PMN), TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 22, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of therapeutic antibodies targeting toxic misfolded proteins in neurodegenerative diseases, such as Alzhiemer's disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), today announced that it has entered

Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025

(NASDAQ:MCRB), CAMBRIDGE, Mass., July 22, 2025 (GLOBE NEWSWIRE) — Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on August 6, 2025 at 8:30 a.m. ET to discuss second quarter 2025 financial results and provide business updates. To access the conference call,

Scroll to Top